

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle fiber development (GO:0048741) | 8.95622823 |
| 2 | actin filament-based movement (GO:0030048) | 8.67197313 |
| 3 | skeletal muscle tissue regeneration (GO:0043403) | 8.60000867 |
| 4 | skeletal muscle adaptation (GO:0043501) | 8.00384570 |
| 5 | myotube cell development (GO:0014904) | 7.57679485 |
| 6 | muscle cell fate commitment (GO:0042693) | 7.21141804 |
| 7 | striated muscle contraction (GO:0006941) | 6.96199563 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.53871763 |
| 9 | regulation of actin filament-based movement (GO:1903115) | 6.24653792 |
| 10 | sarcomere organization (GO:0045214) | 6.22802360 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.94342123 |
| 12 | * muscle contraction (GO:0006936) | 5.90529888 |
| 13 | creatine metabolic process (GO:0006600) | 5.80365547 |
| 14 | response to inactivity (GO:0014854) | 5.75006870 |
| 15 | cardiac muscle hypertrophy (GO:0003300) | 5.62240982 |
| 16 | myofibril assembly (GO:0030239) | 5.57273555 |
| 17 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.55323401 |
| 18 | cytidine deamination (GO:0009972) | 5.48719371 |
| 19 | cytidine metabolic process (GO:0046087) | 5.48719371 |
| 20 | cytidine catabolic process (GO:0006216) | 5.48719371 |
| 21 | NADH metabolic process (GO:0006734) | 5.47450241 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.33627078 |
| 23 | muscle fiber development (GO:0048747) | 5.31674178 |
| 24 | * muscle system process (GO:0003012) | 5.17491760 |
| 25 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.01760561 |
| 26 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.95697160 |
| 27 | striated muscle atrophy (GO:0014891) | 4.89545678 |
| 28 | adult heart development (GO:0007512) | 4.80768465 |
| 29 | muscle hypertrophy (GO:0014896) | 4.75503403 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.74019253 |
| 31 | skeletal muscle tissue development (GO:0007519) | 4.72232691 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.71123925 |
| 33 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.68696213 |
| 34 | striated muscle adaptation (GO:0014888) | 4.65006809 |
| 35 | actomyosin structure organization (GO:0031032) | 4.58857285 |
| 36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.58029537 |
| 37 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.57084402 |
| 38 | carnitine shuttle (GO:0006853) | 4.54817161 |
| 39 | response to muscle activity (GO:0014850) | 4.50845835 |
| 40 | cardiac muscle cell development (GO:0055013) | 4.50818484 |
| 41 | heart process (GO:0003015) | 4.47683288 |
| 42 | heart contraction (GO:0060047) | 4.47683288 |
| 43 | purine nucleotide salvage (GO:0032261) | 4.44402993 |
| 44 | myotube differentiation (GO:0014902) | 4.38466442 |
| 45 | regulation of the force of heart contraction (GO:0002026) | 4.35646990 |
| 46 | glycogen biosynthetic process (GO:0005978) | 4.34226896 |
| 47 | glucan biosynthetic process (GO:0009250) | 4.34226896 |
| 48 | muscle atrophy (GO:0014889) | 4.24397990 |
| 49 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.20280645 |
| 50 | cardiac cell development (GO:0055006) | 4.18542516 |
| 51 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.18451656 |
| 52 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.17312505 |
| 53 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.16699995 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 4.15210205 |
| 55 | glycogen catabolic process (GO:0005980) | 4.11988598 |
| 56 | positive regulation of myotube differentiation (GO:0010831) | 4.11348690 |
| 57 | muscle cell cellular homeostasis (GO:0046716) | 4.09488156 |
| 58 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.09089325 |
| 59 | muscle hypertrophy in response to stress (GO:0003299) | 4.09089325 |
| 60 | cardiac muscle adaptation (GO:0014887) | 4.09089325 |
| 61 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.08582691 |
| 62 | striated muscle cell development (GO:0055002) | 3.99039396 |
| 63 | fatty acid transmembrane transport (GO:1902001) | 3.99011410 |
| 64 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.97234574 |
| 65 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.84893842 |
| 66 | glucan catabolic process (GO:0009251) | 3.84806335 |
| 67 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.84573665 |
| 68 | regulation of relaxation of muscle (GO:1901077) | 3.81907627 |
| 69 | muscle adaptation (GO:0043500) | 3.79239780 |
| 70 | regulation of cofactor metabolic process (GO:0051193) | 3.78288764 |
| 71 | regulation of coenzyme metabolic process (GO:0051196) | 3.78288764 |
| 72 | * muscle organ development (GO:0007517) | 3.77257080 |
| 73 | * muscle structure development (GO:0061061) | 3.71536700 |
| 74 | regulation of p38MAPK cascade (GO:1900744) | 3.71302724 |
| 75 | cardiac muscle contraction (GO:0060048) | 3.65808040 |
| 76 | myoblast fusion (GO:0007520) | 3.65499461 |
| 77 | cardiac myofibril assembly (GO:0055003) | 3.64585993 |
| 78 | tricarboxylic acid cycle (GO:0006099) | 3.60418774 |
| 79 | IMP metabolic process (GO:0046040) | 3.59724695 |
| 80 | regulation of ATPase activity (GO:0043462) | 3.56021320 |
| 81 | regulation of ATP catabolic process (GO:1903289) | 3.56021320 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.54646699 |
| 83 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.54646699 |
| 84 | regulation of sequestering of triglyceride (GO:0010889) | 3.52483639 |
| 85 | cellular polysaccharide catabolic process (GO:0044247) | 3.52307352 |
| 86 | gluconeogenesis (GO:0006094) | 3.52139590 |
| 87 | positive regulation of myoblast differentiation (GO:0045663) | 3.48736515 |
| 88 | glycogen metabolic process (GO:0005977) | 3.47199191 |
| 89 | neuromuscular synaptic transmission (GO:0007274) | 3.46282507 |
| 90 | regulation of muscle contraction (GO:0006937) | 3.45517028 |
| 91 | response to activity (GO:0014823) | 3.45188787 |
| 92 | negative regulation of necroptotic process (GO:0060546) | 3.44657272 |
| 93 | regulation of muscle system process (GO:0090257) | 3.43219753 |
| 94 | negative regulation of muscle contraction (GO:0045932) | 3.42252333 |
| 95 | positive regulation of cation channel activity (GO:2001259) | 3.41946565 |
| 96 | muscle cell development (GO:0055001) | 3.40526499 |
| 97 | glucan metabolic process (GO:0044042) | 3.40104387 |
| 98 | cellular glucan metabolic process (GO:0006073) | 3.40104387 |
| 99 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.38950878 |
| 100 | neuromuscular junction development (GO:0007528) | 3.38261537 |
| 101 | carnitine transmembrane transport (GO:1902603) | 3.37516247 |
| 102 | * skeletal muscle cell differentiation (GO:0035914) | 3.37457022 |
| 103 | polysaccharide catabolic process (GO:0000272) | 3.35480315 |
| 104 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30858142 |
| 105 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.28280260 |
| 106 | negative regulation of protein localization to cell surface (GO:2000009) | 3.23083869 |
| 107 | oxaloacetate metabolic process (GO:0006107) | 3.22544399 |
| 108 | syncytium formation (GO:0006949) | 3.21228865 |
| 109 | otic vesicle formation (GO:0030916) | 3.21013894 |
| 110 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.20080485 |
| 111 | regulation of sulfur metabolic process (GO:0042762) | 3.10748218 |
| 112 | regulation of striated muscle contraction (GO:0006942) | 3.08380978 |
| 113 | carnitine transport (GO:0015879) | 3.07714376 |
| 114 | amino-acid betaine transport (GO:0015838) | 3.07714376 |
| 115 | positive regulation of p38MAPK cascade (GO:1900745) | 3.07084599 |
| 116 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.06662841 |
| 117 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.06662841 |
| 118 | tissue regeneration (GO:0042246) | 3.06558058 |
| 119 | striated muscle tissue development (GO:0014706) | 3.06467699 |
| 120 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.05186951 |
| 121 | regulation of membrane repolarization (GO:0060306) | 3.03961054 |
| 122 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.02132645 |
| 123 | negative regulation of muscle hypertrophy (GO:0014741) | 2.95912090 |
| 124 | muscle tissue morphogenesis (GO:0060415) | 2.95841880 |
| 125 | IMP biosynthetic process (GO:0006188) | 2.91157536 |
| 126 | striated muscle hypertrophy (GO:0014897) | 2.85121543 |
| 127 | muscle filament sliding (GO:0030049) | 14.1044075 |
| 128 | actin-myosin filament sliding (GO:0033275) | 14.1044075 |
| 129 | skeletal muscle contraction (GO:0003009) | 12.4935635 |
| 130 | actin-mediated cell contraction (GO:0070252) | 11.5386757 |
| 131 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.0316173 |
| 132 | plasma membrane repair (GO:0001778) | 10.6535377 |
| 133 | regulation of skeletal muscle contraction (GO:0014819) | 10.1397482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32121482 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.77761387 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63587146 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.43162436 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.42234056 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.96589918 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87024837 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.62837633 |
| 9 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.60234138 |
| 10 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.60234138 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.48241171 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.46991584 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.33652249 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25730232 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24791146 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.23044600 |
| 17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.21185981 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16790522 |
| 19 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.86278621 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.84150830 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79099239 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77052751 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.74983048 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.74479487 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70393167 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65891761 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.62278014 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60969777 |
| 29 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.60890305 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.60576752 |
| 31 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.59506999 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58079704 |
| 33 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.57085882 |
| 34 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.56424988 |
| 35 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.54073669 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52088586 |
| 37 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48440178 |
| 38 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.47959167 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46328818 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45895744 |
| 41 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.43563932 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43137141 |
| 43 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.42491778 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40369763 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39268176 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39268176 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38699790 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35479845 |
| 49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32740362 |
| 50 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32353089 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31252752 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30794963 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29288229 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27541926 |
| 55 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24738620 |
| 56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23626060 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19597197 |
| 58 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18670117 |
| 59 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.16619354 |
| 60 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.16501539 |
| 61 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.15358325 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14524619 |
| 63 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13895373 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13435304 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11681325 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11451301 |
| 67 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09574580 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09137056 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09047005 |
| 70 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.08715447 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08620328 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08449947 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07995136 |
| 74 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07656178 |
| 75 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05930212 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05455463 |
| 77 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04957448 |
| 78 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03334054 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02180941 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00424044 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00371973 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99764501 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99518639 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99226098 |
| 85 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99202991 |
| 86 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98759849 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98407526 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97966526 |
| 89 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.97943581 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 0.96587938 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95902157 |
| 92 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.95836259 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94911976 |
| 94 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.94755255 |
| 95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92088340 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92076525 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91983414 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91799122 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91799122 |
| 100 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.91742512 |
| 101 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89911692 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89803952 |
| 103 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88768172 |
| 104 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88623431 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88262559 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88019684 |
| 107 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.86404980 |
| 108 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85486284 |
| 109 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85446596 |
| 110 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84280276 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83773786 |
| 112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81719176 |
| 113 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.80791008 |
| 114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78492628 |
| 115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76503665 |
| 116 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.75179696 |
| 117 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74248142 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.74215455 |
| 119 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.74195560 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71645675 |
| 121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71112015 |
| 122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70698735 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69825816 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.69443703 |
| 125 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.69245225 |
| 126 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.68787611 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.66922978 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.65441677 |
| 129 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.64849909 |
| 130 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.64313483 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.64253472 |
| 132 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.63431605 |
| 133 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.63185887 |
| 134 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.62870930 |
| 135 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.62725597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.96168571 |
| 2 | MP0000749_muscle_degeneration | 6.14953507 |
| 3 | MP0000751_myopathy | 5.81907849 |
| 4 | MP0003646_muscle_fatigue | 5.51149204 |
| 5 | MP0000747_muscle_weakness | 4.57087960 |
| 6 | MP0000013_abnormal_adipose_tissue | 3.97860444 |
| 7 | MP0002106_abnormal_muscle_physiology | 3.97192353 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.71447269 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.64440445 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.60828943 |
| 11 | MP0005369_muscle_phenotype | 3.50725126 |
| 12 | MP0004036_abnormal_muscle_relaxation | 3.37595804 |
| 13 | MP0000733_abnormal_muscle_development | 3.37159597 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.30819648 |
| 15 | MP0002269_muscular_atrophy | 3.16467017 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.78166645 |
| 17 | MP0004130_abnormal_muscle_cell | 2.64491029 |
| 18 | MP0002108_abnormal_muscle_morphology | 2.63174592 |
| 19 | MP0004233_abnormal_muscle_weight | 2.49619933 |
| 20 | MP0005330_cardiomyopathy | 2.34108669 |
| 21 | MP0004270_analgesia | 2.13497520 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.01122545 |
| 23 | MP0000003_abnormal_adipose_tissue | 1.86503976 |
| 24 | MP0004215_abnormal_myocardial_fiber | 1.84173179 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.75318342 |
| 26 | MP0002971_abnormal_brown_adipose | 1.66847764 |
| 27 | MP0005375_adipose_tissue_phenotype | 1.66422890 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.64092069 |
| 29 | MP0004484_altered_response_of | 1.62887185 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.59407366 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.50484599 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.45398787 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.38590585 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.34327352 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08922311 |
| 36 | MP0002234_abnormal_pharynx_morphology | 0.99114481 |
| 37 | MP0005385_cardiovascular_system_phenoty | 0.98433820 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 0.98433820 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 0.96297389 |
| 40 | MP0001661_extended_life_span | 0.95231599 |
| 41 | MP0005266_abnormal_metabolism | 0.87920030 |
| 42 | MP0004134_abnormal_chest_morphology | 0.87766226 |
| 43 | MP0005275_abnormal_skin_tensile | 0.85691716 |
| 44 | MP0003137_abnormal_impulse_conducting | 0.82668471 |
| 45 | MP0000762_abnormal_tongue_morphology | 0.79772700 |
| 46 | MP0005165_increased_susceptibility_to | 0.79423678 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 0.78641613 |
| 48 | MP0001299_abnormal_eye_distance/ | 0.78288220 |
| 49 | MP0006138_congestive_heart_failure | 0.67593034 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 0.66753029 |
| 51 | MP0008961_abnormal_basal_metabolism | 0.63050388 |
| 52 | MP0009250_abnormal_appendicular_skeleto | 0.62953655 |
| 53 | MP0005670_abnormal_white_adipose | 0.58476526 |
| 54 | MP0002822_catalepsy | 0.56040803 |
| 55 | MP0008775_abnormal_heart_ventricle | 0.55382694 |
| 56 | MP0000579_abnormal_nail_morphology | 0.54932217 |
| 57 | MP0002127_abnormal_cardiovascular_syste | 0.52458702 |
| 58 | MP0000266_abnormal_heart_morphology | 0.51555455 |
| 59 | MP0004147_increased_porphyrin_level | 0.50335741 |
| 60 | MP0004043_abnormal_pH_regulation | 0.49938086 |
| 61 | MP0005503_abnormal_tendon_morphology | 0.49656702 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 0.48374421 |
| 63 | MP0000343_altered_response_to | 0.48301504 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.47118931 |
| 65 | MP0009672_abnormal_birth_weight | 0.46509560 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 0.46289691 |
| 67 | MP0003828_pulmonary_edema | 0.45735751 |
| 68 | MP0002114_abnormal_axial_skeleton | 0.45274135 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 0.44625388 |
| 70 | MP0004510_myositis | 0.44414055 |
| 71 | MP0005166_decreased_susceptibility_to | 0.41935652 |
| 72 | MP0005452_abnormal_adipose_tissue | 0.41860390 |
| 73 | MP0004197_abnormal_fetal_growth/weight/ | 0.41720651 |
| 74 | MP0003045_fibrosis | 0.40523044 |
| 75 | MP0003879_abnormal_hair_cell | 0.40220824 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.39507463 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38726890 |
| 78 | MP0002796_impaired_skin_barrier | 0.38588765 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.38346842 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.37194670 |
| 81 | MP0004085_abnormal_heartbeat | 0.37067390 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.36940478 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.36338406 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.36283521 |
| 85 | MP0008569_lethality_at_weaning | 0.35483474 |
| 86 | MP0005334_abnormal_fat_pad | 0.35295576 |
| 87 | MP0005501_abnormal_skin_physiology | 0.34700841 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.34228666 |
| 89 | MP0001943_abnormal_respiration | 0.34104726 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.33779603 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 0.30686559 |
| 92 | MP0001849_ear_inflammation | 0.29238776 |
| 93 | MP0003948_abnormal_gas_homeostasis | 0.28913143 |
| 94 | MP0005083_abnormal_biliary_tract | 0.28453618 |
| 95 | MP0004142_abnormal_muscle_tone | 0.28323900 |
| 96 | MP0005332_abnormal_amino_acid | 0.27935459 |
| 97 | MP0001243_abnormal_dermal_layer | 0.27834718 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.27442055 |
| 99 | MP0002128_abnormal_blood_circulation | 0.26923788 |
| 100 | MP0005187_abnormal_penis_morphology | 0.26365151 |
| 101 | MP0009840_abnormal_foam_cell | 0.24606263 |
| 102 | MP0010030_abnormal_orbit_morphology | 0.24179594 |
| 103 | MP0003941_abnormal_skin_development | 0.23811922 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.22832090 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.22399395 |
| 106 | MP0000427_abnormal_hair_cycle | 0.21769735 |
| 107 | MP0005535_abnormal_body_temperature | 0.21562752 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.20762529 |
| 109 | MP0000383_abnormal_hair_follicle | 0.20596510 |
| 110 | MP0005451_abnormal_body_composition | 0.20350716 |
| 111 | MP0003959_abnormal_lean_body | 0.19952005 |
| 112 | MP0009115_abnormal_fat_cell | 0.19697183 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.18540053 |
| 114 | MP0002066_abnormal_motor_capabilities/c | 0.17205464 |
| 115 | MP0008874_decreased_physiological_sensi | 0.16671895 |
| 116 | MP0005386_behavior/neurological_phenoty | 0.16188193 |
| 117 | MP0004924_abnormal_behavior | 0.16188193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 9.38467080 |
| 2 | Distal arthrogryposis (HP:0005684) | 7.46618100 |
| 3 | Myopathic facies (HP:0002058) | 6.53978575 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.47360152 |
| 5 | Round ear (HP:0100830) | 5.70042468 |
| 6 | Ulnar deviation of the wrist (HP:0003049) | 5.59444063 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 5.34347825 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 5.24701184 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.11638262 |
| 10 | Calcaneovalgus deformity (HP:0001848) | 4.89157210 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.87450520 |
| 12 | Deformed tarsal bones (HP:0008119) | 4.85117084 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 4.55695835 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.46859552 |
| 15 | Absent phalangeal crease (HP:0006109) | 4.33984070 |
| 16 | Difficulty running (HP:0009046) | 4.15979262 |
| 17 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.10662851 |
| 18 | Bundle branch block (HP:0011710) | 4.09888513 |
| 19 | Neck muscle weakness (HP:0000467) | 3.97797986 |
| 20 | Increased connective tissue (HP:0009025) | 3.80209890 |
| 21 | Fetal akinesia sequence (HP:0001989) | 3.75402886 |
| 22 | Malignant hyperthermia (HP:0002047) | 3.73645360 |
| 23 | Frequent falls (HP:0002359) | 3.72639650 |
| 24 | Myoglobinuria (HP:0002913) | 3.66727751 |
| 25 | Muscle stiffness (HP:0003552) | 3.66551229 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.63744881 |
| 27 | Abnormal finger flexion creases (HP:0006143) | 3.61749848 |
| 28 | Rimmed vacuoles (HP:0003805) | 3.56938818 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.53860088 |
| 30 | Fatigable weakness (HP:0003473) | 3.36822447 |
| 31 | Abnormality of the neuromuscular junction (HP:0003398) | 3.36822447 |
| 32 | Areflexia of lower limbs (HP:0002522) | 3.33641767 |
| 33 | Myotonia (HP:0002486) | 3.17198986 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 3.09405921 |
| 35 | Rhabdomyolysis (HP:0003201) | 3.07685803 |
| 36 | Bulbar palsy (HP:0001283) | 3.06847775 |
| 37 | Progressive muscle weakness (HP:0003323) | 3.00242130 |
| 38 | Slender build (HP:0001533) | 2.99365193 |
| 39 | Abnormality of the calcaneus (HP:0008364) | 2.98098802 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.93476330 |
| 41 | Weak cry (HP:0001612) | 2.93175260 |
| 42 | Difficulty climbing stairs (HP:0003551) | 2.81446442 |
| 43 | EMG: neuropathic changes (HP:0003445) | 2.79552647 |
| 44 | Gowers sign (HP:0003391) | 2.78654155 |
| 45 | Hip contracture (HP:0003273) | 2.75342258 |
| 46 | Generalized muscle weakness (HP:0003324) | 2.71319389 |
| 47 | Facial diplegia (HP:0001349) | 2.64753100 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63801246 |
| 49 | Spinal rigidity (HP:0003306) | 2.62336846 |
| 50 | Heart block (HP:0012722) | 2.60442457 |
| 51 | Shoulder girdle muscle weakness (HP:0003547) | 2.51128457 |
| 52 | Scapular winging (HP:0003691) | 2.50446152 |
| 53 | Type 2 muscle fiber atrophy (HP:0003554) | 2.49913173 |
| 54 | Pelvic girdle muscle weakness (HP:0003749) | 2.49575840 |
| 55 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.47264705 |
| 56 | Subaortic stenosis (HP:0001682) | 2.47264705 |
| 57 | Abnormal atrioventricular conduction (HP:0005150) | 2.46869165 |
| 58 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.41489862 |
| 59 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.41489862 |
| 60 | Ragged-red muscle fibers (HP:0003200) | 2.41421863 |
| 61 | Proximal amyotrophy (HP:0007126) | 2.36547413 |
| 62 | Popliteal pterygium (HP:0009756) | 2.30417413 |
| 63 | Sudden death (HP:0001699) | 2.30358305 |
| 64 | Asymmetric septal hypertrophy (HP:0001670) | 2.28807529 |
| 65 | Muscle fiber atrophy (HP:0100295) | 2.26142057 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.24778242 |
| 67 | Ulnar deviation of finger (HP:0009465) | 2.21517898 |
| 68 | Ventricular arrhythmia (HP:0004308) | 2.20251821 |
| 69 | Waddling gait (HP:0002515) | 2.13947258 |
| 70 | Atrial fibrillation (HP:0005110) | 2.12193550 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.11686765 |
| 72 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.11598800 |
| 73 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.10376688 |
| 74 | Hyperkalemia (HP:0002153) | 2.08682150 |
| 75 | Amniotic constriction ring (HP:0009775) | 2.04052716 |
| 76 | Abnormality of placental membranes (HP:0011409) | 2.04052716 |
| 77 | Easy fatigability (HP:0003388) | 2.03748740 |
| 78 | Muscle fiber inclusion bodies (HP:0100299) | 12.2626283 |
| 79 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 11.4184255 |
| 80 | Nemaline bodies (HP:0003798) | 11.2840663 |
| 81 | Nonprogressive disorder (HP:0003680) | 1.97742846 |
| 82 | Muscular dystrophy (HP:0003560) | 1.97172280 |
| 83 | Metatarsus adductus (HP:0001840) | 1.94541014 |
| 84 | Primary atrial arrhythmia (HP:0001692) | 1.92942938 |
| 85 | Exercise intolerance (HP:0003546) | 1.88534006 |
| 86 | Limb-girdle muscle weakness (HP:0003325) | 1.88349412 |
| 87 | Limited hip movement (HP:0008800) | 1.88308487 |
| 88 | Supraventricular tachycardia (HP:0004755) | 1.87848561 |
| 89 | Right ventricular cardiomyopathy (HP:0011663) | 1.87822774 |
| 90 | Paralysis (HP:0003470) | 1.82476662 |
| 91 | Supraventricular arrhythmia (HP:0005115) | 1.82191694 |
| 92 | Atrioventricular block (HP:0001678) | 1.81752307 |
| 93 | Achilles tendon contracture (HP:0001771) | 1.81735389 |
| 94 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.81025739 |
| 95 | Hypoplastic ischia (HP:0003175) | 1.80991777 |
| 96 | Syncope (HP:0001279) | 1.79919334 |
| 97 | Palpitations (HP:0001962) | 1.79116767 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78127538 |
| 99 | Aplasia of the musculature (HP:0100854) | 1.76945040 |
| 100 | Ventricular fibrillation (HP:0001663) | 1.71993092 |
| 101 | Increased muscle lipid content (HP:0009058) | 1.67818161 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 1.67312853 |
| 103 | Tarsal synostosis (HP:0008368) | 1.63789418 |
| 104 | Lower limb amyotrophy (HP:0007210) | 1.61202963 |
| 105 | Abnormality of the ischium (HP:0003174) | 1.57587141 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 1.55188790 |
| 107 | Adducted thumb (HP:0001181) | 1.52754371 |
| 108 | Ventricular tachycardia (HP:0004756) | 1.52054435 |
| 109 | Abnormality of the foot musculature (HP:0001436) | 1.51630146 |
| 110 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.51064476 |
| 111 | Dilated cardiomyopathy (HP:0001644) | 1.50889268 |
| 112 | Long clavicles (HP:0000890) | 1.50870292 |
| 113 | Steppage gait (HP:0003376) | 1.46961742 |
| 114 | Left ventricular hypertrophy (HP:0001712) | 1.46736112 |
| 115 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.46583673 |
| 116 | Synostosis involving bones of the feet (HP:0009140) | 1.46583673 |
| 117 | Congenital hip dislocation (HP:0001374) | 1.46079179 |
| 118 | Akinesia (HP:0002304) | 1.45146422 |
| 119 | Lipoatrophy (HP:0100578) | 1.39033290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.55689100 |
| 2 | PIK3CG | 4.49100489 |
| 3 | NME1 | 3.62357779 |
| 4 | MUSK | 3.59631569 |
| 5 | PHKG1 | 2.99952317 |
| 6 | PHKG2 | 2.99952317 |
| 7 | TRIB3 | 2.65709260 |
| 8 | MAP2K3 | 2.41251598 |
| 9 | OBSCN | 11.9271415 |
| 10 | PINK1 | 1.87845668 |
| 11 | NEK1 | 1.87620857 |
| 12 | DMPK | 1.85094903 |
| 13 | MAP3K7 | 1.84622279 |
| 14 | MYLK | 1.78792344 |
| 15 | PDK3 | 1.69556372 |
| 16 | PDK4 | 1.69556372 |
| 17 | MAPK12 | 1.49792970 |
| 18 | MAP2K4 | 1.24365291 |
| 19 | MAP3K3 | 1.15598899 |
| 20 | PDK2 | 1.11456323 |
| 21 | BCKDK | 1.08319667 |
| 22 | MAP2K6 | 1.06496343 |
| 23 | MARK1 | 1.02367743 |
| 24 | PKN2 | 1.02060994 |
| 25 | MAPKAPK3 | 0.89834119 |
| 26 | PIK3CA | 0.88482544 |
| 27 | MOS | 0.85259249 |
| 28 | EPHB1 | 0.79299691 |
| 29 | LIMK1 | 0.79079143 |
| 30 | MAP2K1 | 0.73656910 |
| 31 | CAMK2G | 0.66555363 |
| 32 | ILK | 0.66170932 |
| 33 | CAMK4 | 0.63445538 |
| 34 | NEK9 | 0.60348162 |
| 35 | MAP3K13 | 0.59430370 |
| 36 | TAOK1 | 0.58198902 |
| 37 | TAOK2 | 0.56025736 |
| 38 | MAP3K11 | 0.54740108 |
| 39 | PAK3 | 0.53545905 |
| 40 | ZAK | 0.53111518 |
| 41 | ERN1 | 0.48975129 |
| 42 | CAMK1 | 0.48810973 |
| 43 | PRKAA1 | 0.44355920 |
| 44 | ARAF | 0.44133402 |
| 45 | PTK6 | 0.43648975 |
| 46 | MAPK11 | 0.43335698 |
| 47 | ROCK1 | 0.42291354 |
| 48 | RPS6KC1 | 0.41744560 |
| 49 | RPS6KL1 | 0.41744560 |
| 50 | SGK3 | 0.41207373 |
| 51 | RIPK1 | 0.37717480 |
| 52 | ERBB3 | 0.37439608 |
| 53 | TRPM7 | 0.36944586 |
| 54 | PRKAA2 | 0.36313228 |
| 55 | PRPF4B | 0.34467676 |
| 56 | RPS6KA6 | 0.34394993 |
| 57 | EPHA3 | 0.30845024 |
| 58 | PRKG1 | 0.29721140 |
| 59 | DAPK2 | 0.27503672 |
| 60 | MAP3K5 | 0.27465071 |
| 61 | SGK1 | 0.27444344 |
| 62 | EEF2K | 0.26188450 |
| 63 | CDC42BPA | 0.25986888 |
| 64 | MAPK4 | 0.25471507 |
| 65 | PKN1 | 0.24629352 |
| 66 | * AKT2 | 0.24397939 |
| 67 | RPS6KA1 | 0.23809246 |
| 68 | CAMK2D | 0.23676889 |
| 69 | LATS2 | 0.23667844 |
| 70 | KSR2 | 0.21970300 |
| 71 | PDPK1 | 0.21720702 |
| 72 | SGK2 | 0.21453701 |
| 73 | TIE1 | 0.21193639 |
| 74 | TGFBR2 | 0.20989290 |
| 75 | SIK1 | 0.20530980 |
| 76 | MAPK7 | 0.20381950 |
| 77 | CDK6 | 0.19880501 |
| 78 | STK4 | 0.19830914 |
| 79 | MAP3K1 | 0.19731523 |
| 80 | MAP3K6 | 0.19150093 |
| 81 | LRRK2 | 0.19081242 |
| 82 | RPS6KA3 | 0.18827370 |
| 83 | DAPK3 | 0.16875359 |
| 84 | PRKACB | 0.16248715 |
| 85 | PRKACG | 0.16220461 |
| 86 | ROCK2 | 0.16122519 |
| 87 | FER | 0.15836645 |
| 88 | BRAF | 0.15643727 |
| 89 | RPS6KB1 | 0.15485130 |
| 90 | MARK2 | 0.15458465 |
| 91 | ZAP70 | 0.14970744 |
| 92 | RAF1 | 0.14805305 |
| 93 | STK24 | 0.14766113 |
| 94 | ICK | 0.14586700 |
| 95 | PDK1 | 0.14137598 |
| 96 | PDGFRA | 0.12676664 |
| 97 | PRKACA | 0.12587181 |
| 98 | PTK2B | 0.12545440 |
| 99 | MAP3K9 | 0.12037717 |
| 100 | INSRR | 0.11737506 |
| 101 | PAK4 | 0.11432799 |
| 102 | PRKD1 | 0.11307774 |
| 103 | MARK3 | 0.10064055 |
| 104 | KSR1 | 0.10010427 |
| 105 | DYRK1B | 0.09828641 |
| 106 | BMX | 0.09710589 |
| 107 | ABL2 | 0.09227132 |
| 108 | EPHB2 | 0.08547486 |
| 109 | TESK1 | 0.07986893 |
| 110 | RPS6KB2 | 0.06872171 |
| 111 | PAK6 | 0.06835239 |
| 112 | STK11 | 0.06324175 |
| 113 | MST1R | 0.06307430 |
| 114 | CAMK2A | 0.06213311 |
| 115 | GSK3A | 0.06087268 |
| 116 | NLK | 0.05710561 |
| 117 | RET | 0.05586521 |
| 118 | PIM2 | 0.05192819 |
| 119 | MAPK10 | 0.05167874 |
| 120 | FLT3 | 0.04915722 |
| 121 | MTOR | 0.03793519 |
| 122 | CCNB1 | 0.02607032 |
| 123 | PRKCH | 0.02501244 |
| 124 | LATS1 | 0.00999263 |
| 125 | MAP3K10 | 0.00820402 |
| 126 | MAPK8 | 0.00795604 |
| 127 | CAMK2B | 0.00571197 |
| 128 | DDR2 | 0.00423045 |
| 129 | JAK2 | 0.00331697 |
| 130 | TBK1 | -0.0071726 |
| 131 | FGFR1 | -0.0008802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.50938584 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.30299986 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.01384611 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.97637458 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.81449609 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.35638747 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74996998 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.51670292 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27472683 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.01710726 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 1.98208209 |
| 12 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.96794732 |
| 13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.88589741 |
| 14 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.82870465 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81385056 |
| 16 | Insulin resistance_Homo sapiens_hsa04931 | 1.69040363 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.64295141 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.61022646 |
| 19 | Tight junction_Homo sapiens_hsa04530 | 1.58375124 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.56001407 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50085360 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47783504 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47520952 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.46849221 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38019962 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34826945 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34589381 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30315129 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.29836173 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27942681 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25213626 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19220410 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13102078 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.11018167 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08752472 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.07510522 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05531242 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02407868 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99698454 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97012180 |
| 41 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88582755 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87536597 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86928030 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84557900 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84029865 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83909989 |
| 47 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83521365 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78445458 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70336239 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70172591 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67874512 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 0.67793625 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64945619 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64360816 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63871745 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62918555 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61693072 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60610983 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59083332 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.58273587 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57898938 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57542877 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55913207 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53662724 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.52047998 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.49372567 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47736773 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46655882 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43638548 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43011016 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41830721 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41031846 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39230487 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39005629 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37325745 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.36304913 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33642541 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32852435 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31644744 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30820646 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.29927707 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.29642921 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29503652 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28961031 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28277541 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27390765 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.26973550 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26834152 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25530947 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.24469861 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23434869 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22538561 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22217175 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22211246 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.21083751 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20116153 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.19721783 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19393325 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18228555 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17114055 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16895059 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.16337750 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14418042 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14246109 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13864347 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13613946 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12840811 |
| 108 | Melanogenesis_Homo sapiens_hsa04916 | 0.12775784 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.12432611 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12005292 |
| 111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.11869871 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11763469 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11095301 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.11061714 |
| 115 | Gap junction_Homo sapiens_hsa04540 | 0.10872909 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.10700417 |
| 117 | Proteasome_Homo sapiens_hsa03050 | 0.09239896 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.08517982 |

